Guidelines on the investigation and management of antiphospholipid syndrome
Identifieur interne : 001D71 ( Istex/Corpus ); précédent : 001D70; suivant : 001D72Guidelines on the investigation and management of antiphospholipid syndrome
Auteurs : David Keeling ; Ian Mackie ; Gary W. Moore ; Ian A. Greer ; Michael GreavesSource :
- British Journal of Haematology [ 0007-1048 ] ; 2012-04.
English descriptors
- Teeft :
- American journal, Antibody, Anticardiolipin, Anticardiolipin antibodies, Anticoagulant, Anticoagulation, Antiphospholipid, Antiphospholipid antibodies, Antiphospholipid antibody syndrome, Antiphospholipid syndrome, Antiphospholipid units, Antiplatelet, Antiplatelet therapy, Antiprothrombin antibodies, Aptt, Arterial thrombosis, Aspirin, Assay, Asymptomatic carriers, Atsumi, B2gpi, Blackwell publishing, Blood coagulation, British committee, British journal, British journal haematology, Centile, Clinical laboratory, Coagulation, Complement activation, Derksen, Dose aspirin, Drvvt, Endothelial cells, England journal, Fetal, Greaves, Groot, Guideline, Haematology, Haemostasis, Heparin, High risk, Human reproduction, Internal medicine, Ischaemic, Ischaemic stroke, Ischemic stroke, Khamashta, Lmwh, Lupus, Lupus anticoagulant, Lupus anticoagulants, Miscarriage, Molecular weight heparin, Morbidity, More occasions, Multiple sclerosis, Myocardial infarction, Obstetrics, Phospholipid, Phospholipid dependence, Pierangeli, Platelet, Pregnancy, Pregnancy failure, Pregnancy loss, Pregnancy morbidity, Prothrombin, Randomized, Reagent, Recurrence, Recurrent, Recurrent miscarriage, Recurrent pregnancy loss, Rosove brewer, Solid phase, Syndrome, Systematic review, Systemic lupus erythematosus, Thromboembolism, Thrombosis, Thrombosis research, Transient risk factor, Unfractionated heparin, Venous, Venous thromboembolism, Venous thrombosis, Viper venom time, Warfarin.
Url:
DOI: 10.1111/j.1365-2141.2012.09037.x
Links to Exploration step
ISTEX:77FB09242F766C204AA3EDEAB0546B376358BD0CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Guidelines on the investigation and management of antiphospholipid syndrome</title><author><name sortKey="Keeling, David" sort="Keeling, David" uniqKey="Keeling D" first="David" last="Keeling">David Keeling</name><affiliation><mods:affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence: David Keeling, c/o BCSH Secretary, British Society for Haematology, 100 White Lion Street, London N1 9PF, UK.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: bcsh@b-s-h.org.uk</mods:affiliation></affiliation></author><author><name sortKey="Mackie, Ian" sort="Mackie, Ian" uniqKey="Mackie I" first="Ian" last="Mackie">Ian Mackie</name><affiliation><mods:affiliation>Haemostasis Research Unit, Haematology Department, University College London, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Moore, Gary W" sort="Moore, Gary W" uniqKey="Moore G" first="Gary W." last="Moore">Gary W. Moore</name><affiliation><mods:affiliation>Centre for Haemostasis and Thrombosis, GSTS Pathology, Guy's & St. Thomas’ Hospitals, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Greer, Ian A" sort="Greer, Ian A" uniqKey="Greer I" first="Ian A." last="Greer">Ian A. Greer</name><affiliation><mods:affiliation>University of Liverpool, Liverpool, UK</mods:affiliation></affiliation></author><author><name sortKey="Greaves, Michael" sort="Greaves, Michael" uniqKey="Greaves M" first="Michael" last="Greaves">Michael Greaves</name><affiliation><mods:affiliation>School of Medicine & Dentistry, University of Aberdeen, Aberdeen, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:77FB09242F766C204AA3EDEAB0546B376358BD0C</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1111/j.1365-2141.2012.09037.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-JMFFLXHG-G/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001D71</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D71</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Guidelines on the investigation and management of antiphospholipid syndrome</title><author><name sortKey="Keeling, David" sort="Keeling, David" uniqKey="Keeling D" first="David" last="Keeling">David Keeling</name><affiliation><mods:affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence: David Keeling, c/o BCSH Secretary, British Society for Haematology, 100 White Lion Street, London N1 9PF, UK.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: bcsh@b-s-h.org.uk</mods:affiliation></affiliation></author><author><name sortKey="Mackie, Ian" sort="Mackie, Ian" uniqKey="Mackie I" first="Ian" last="Mackie">Ian Mackie</name><affiliation><mods:affiliation>Haemostasis Research Unit, Haematology Department, University College London, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Moore, Gary W" sort="Moore, Gary W" uniqKey="Moore G" first="Gary W." last="Moore">Gary W. Moore</name><affiliation><mods:affiliation>Centre for Haemostasis and Thrombosis, GSTS Pathology, Guy's & St. Thomas’ Hospitals, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Greer, Ian A" sort="Greer, Ian A" uniqKey="Greer I" first="Ian A." last="Greer">Ian A. Greer</name><affiliation><mods:affiliation>University of Liverpool, Liverpool, UK</mods:affiliation></affiliation></author><author><name sortKey="Greaves, Michael" sort="Greaves, Michael" uniqKey="Greaves M" first="Michael" last="Greaves">Michael Greaves</name><affiliation><mods:affiliation>School of Medicine & Dentistry, University of Aberdeen, Aberdeen, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Journal of Haematology</title><title level="j" type="alt">BRITISH JOURNAL OF HAEMATOLOGY</title><idno type="ISSN">0007-1048</idno><idno type="eISSN">1365-2141</idno><imprint><biblScope unit="vol">157</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="47">47</biblScope><biblScope unit="page" to="58">58</biblScope><biblScope unit="page-count">12</biblScope><date type="published" when="2012-04">2012-04</date></imprint><idno type="ISSN">0007-1048</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1048</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>American journal</term><term>Antibody</term><term>Anticardiolipin</term><term>Anticardiolipin antibodies</term><term>Anticoagulant</term><term>Anticoagulation</term><term>Antiphospholipid</term><term>Antiphospholipid antibodies</term><term>Antiphospholipid antibody syndrome</term><term>Antiphospholipid syndrome</term><term>Antiphospholipid units</term><term>Antiplatelet</term><term>Antiplatelet therapy</term><term>Antiprothrombin antibodies</term><term>Aptt</term><term>Arterial thrombosis</term><term>Aspirin</term><term>Assay</term><term>Asymptomatic carriers</term><term>Atsumi</term><term>B2gpi</term><term>Blackwell publishing</term><term>Blood coagulation</term><term>British committee</term><term>British journal</term><term>British journal haematology</term><term>Centile</term><term>Clinical laboratory</term><term>Coagulation</term><term>Complement activation</term><term>Derksen</term><term>Dose aspirin</term><term>Drvvt</term><term>Endothelial cells</term><term>England journal</term><term>Fetal</term><term>Greaves</term><term>Groot</term><term>Guideline</term><term>Haematology</term><term>Haemostasis</term><term>Heparin</term><term>High risk</term><term>Human reproduction</term><term>Internal medicine</term><term>Ischaemic</term><term>Ischaemic stroke</term><term>Ischemic stroke</term><term>Khamashta</term><term>Lmwh</term><term>Lupus</term><term>Lupus anticoagulant</term><term>Lupus anticoagulants</term><term>Miscarriage</term><term>Molecular weight heparin</term><term>Morbidity</term><term>More occasions</term><term>Multiple sclerosis</term><term>Myocardial infarction</term><term>Obstetrics</term><term>Phospholipid</term><term>Phospholipid dependence</term><term>Pierangeli</term><term>Platelet</term><term>Pregnancy</term><term>Pregnancy failure</term><term>Pregnancy loss</term><term>Pregnancy morbidity</term><term>Prothrombin</term><term>Randomized</term><term>Reagent</term><term>Recurrence</term><term>Recurrent</term><term>Recurrent miscarriage</term><term>Recurrent pregnancy loss</term><term>Rosove brewer</term><term>Solid phase</term><term>Syndrome</term><term>Systematic review</term><term>Systemic lupus erythematosus</term><term>Thromboembolism</term><term>Thrombosis</term><term>Thrombosis research</term><term>Transient risk factor</term><term>Unfractionated heparin</term><term>Venous</term><term>Venous thromboembolism</term><term>Venous thrombosis</term><term>Viper venom time</term><term>Warfarin</term></keywords></textClass></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>antiphospholipid</json:string><json:string>thrombosis</json:string><json:string>anticoagulant</json:string><json:string>lupus</json:string><json:string>antiphospholipid syndrome</json:string><json:string>guideline</json:string><json:string>haemostasis</json:string><json:string>venous</json:string><json:string>haematology</json:string><json:string>antiphospholipid antibodies</json:string><json:string>heparin</json:string><json:string>anticardiolipin</json:string><json:string>phospholipid</json:string><json:string>british journal</json:string><json:string>randomized</json:string><json:string>khamashta</json:string><json:string>lupus anticoagulant</json:string><json:string>anticardiolipin antibodies</json:string><json:string>ischaemic</json:string><json:string>coagulation</json:string><json:string>warfarin</json:string><json:string>venous thrombosis</json:string><json:string>blackwell publishing</json:string><json:string>syndrome</json:string><json:string>ischaemic stroke</json:string><json:string>greaves</json:string><json:string>assay</json:string><json:string>lupus anticoagulants</json:string><json:string>platelet</json:string><json:string>pregnancy loss</json:string><json:string>dose aspirin</json:string><json:string>atsumi</json:string><json:string>lmwh</json:string><json:string>reagent</json:string><json:string>pierangeli</json:string><json:string>derksen</json:string><json:string>thromboembolism</json:string><json:string>aspirin</json:string><json:string>recurrence</json:string><json:string>anticoagulation</json:string><json:string>b2gpi</json:string><json:string>morbidity</json:string><json:string>miscarriage</json:string><json:string>blood coagulation</json:string><json:string>drvvt</json:string><json:string>aptt</json:string><json:string>antiplatelet</json:string><json:string>systematic review</json:string><json:string>fetal</json:string><json:string>american journal</json:string><json:string>obstetrics</json:string><json:string>centile</json:string><json:string>prothrombin</json:string><json:string>groot</json:string><json:string>pregnancy morbidity</json:string><json:string>arterial thrombosis</json:string><json:string>thrombosis research</json:string><json:string>myocardial infarction</json:string><json:string>systemic lupus erythematosus</json:string><json:string>recurrent pregnancy loss</json:string><json:string>pregnancy</json:string><json:string>recurrent miscarriage</json:string><json:string>phospholipid dependence</json:string><json:string>british journal haematology</json:string><json:string>human reproduction</json:string><json:string>internal medicine</json:string><json:string>antiphospholipid antibody syndrome</json:string><json:string>unfractionated heparin</json:string><json:string>venous thromboembolism</json:string><json:string>clinical laboratory</json:string><json:string>antibody</json:string><json:string>asymptomatic carriers</json:string><json:string>solid phase</json:string><json:string>endothelial cells</json:string><json:string>multiple sclerosis</json:string><json:string>rosove brewer</json:string><json:string>antiprothrombin antibodies</json:string><json:string>british committee</json:string><json:string>transient risk factor</json:string><json:string>antiphospholipid units</json:string><json:string>high risk</json:string><json:string>england journal</json:string><json:string>more occasions</json:string><json:string>ischemic stroke</json:string><json:string>pregnancy failure</json:string><json:string>complement activation</json:string><json:string>molecular weight heparin</json:string><json:string>viper venom time</json:string><json:string>antiplatelet therapy</json:string><json:string>recurrent</json:string></teeft></keywords><author><json:item><name>David Keeling</name><affiliations><json:string>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK</json:string><json:string>Correspondence: David Keeling, c/o BCSH Secretary, British Society for Haematology, 100 White Lion Street, London N1 9PF, UK.E‐mail:</json:string><json:string>E-mail: bcsh@b-s-h.org.uk</json:string></affiliations></json:item><json:item><name>Ian Mackie</name><affiliations><json:string>Haemostasis Research Unit, Haematology Department, University College London, London, UK</json:string></affiliations></json:item><json:item><name>Gary W. Moore</name><affiliations><json:string>Centre for Haemostasis and Thrombosis, GSTS Pathology, Guy's & St. Thomas’ Hospitals, London, UK</json:string></affiliations></json:item><json:item><name>Ian A. Greer</name><affiliations><json:string>University of Liverpool, Liverpool, UK</json:string></affiliations></json:item><json:item><name>Michael Greaves</name><affiliations><json:string>School of Medicine & Dentistry, University of Aberdeen, Aberdeen, UK</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>antiphospholipid syndrome</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>antiphospholid antibodies</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>thrombophilia</value></json:item></subject><articleId><json:string>BJH9037</json:string></articleId><arkIstex>ark:/67375/WNG-JMFFLXHG-G</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><qualityIndicators><score>7.012</score><pdfWordCount>9607</pdfWordCount><pdfCharCount>62809</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>12</pdfPageCount><pdfPageSize>595.276 x 799.37 pts</pdfPageSize><pdfWordsPerPage>801</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>1</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>3</keywordCount></qualityIndicators><title>Guidelines on the investigation and management of antiphospholipid syndrome</title><pmid><json:string>22313321</json:string></pmid><corporate><json:item><name>British Committee for Standards in Haematology</name></json:item></corporate><genre><json:string>article</json:string></genre><host><title>British Journal of Haematology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-2141</json:string></doi><issn><json:string>0007-1048</json:string></issn><eissn><json:string>1365-2141</json:string></eissn><publisherId><json:string>BJH</json:string></publisherId><volume>157</volume><issue>1</issue><pages><first>47</first><last>58</last><total>12</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Guideline</value></json:item><json:item><value>Guideline</value></json:item></subject></host><namedEntities><unitex><date><json:string>2000</json:string><json:string>1990s</json:string><json:string>2012-01-11</json:string><json:string>1770</json:string></date><geogName></geogName><orgName><json:string>Sons, Inc.</json:string><json:string>British Committee for Standards</json:string><json:string>Society for Haematology</json:string><json:string>UK Keywords</json:string><json:string>Churchill Hospital, Oxford, UK</json:string><json:string>University of Liverpool</json:string><json:string>University of Aberdeen</json:string><json:string>Haemostasis Research Unit, Haematology Department, University College London, London, UK</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Gary W. Moore</json:string><json:string>Incidental</json:string><json:string>Michael Greaves</json:string><json:string>John Wiley</json:string><json:string>The</json:string><json:string>Task Force</json:string><json:string>Ian A. Greer</json:string></persName><placeName><json:string>Aberdeen</json:string><json:string>Leiden</json:string><json:string>UK</json:string><json:string>London</json:string><json:string>Liverpool</json:string></placeName><ref_url><json:string>http://www.bcshguidelines.com/BCSH_PROCESS/EVIDENCE_LEVELS_AND_GRADES_OF_RECOMMEN</json:string><json:string>http://www.rcog</json:string></ref_url><ref_bibl><json:string>Espinola et al, 2002</json:string><json:string>Schjetlein et al, 1993</json:string><json:string>Giannakopoulos et al (2007)</json:string><json:string>Branch & Rodgers, 1993</json:string><json:string>Khamashta et al, 1995</json:string><json:string>Liestol et al, 2002</json:string><json:string>Topping et al, 1999</json:string><json:string>Farquharson et al, 2002</json:string><json:string>Rosborough et al, 2010</json:string><json:string>Giron-Gonzalez et al, 2004</json:string><json:string>Rai et al, 1997</json:string><json:string>Levine et al, 2004</json:string><json:string>Urbanus et al, 2009</json:string><json:string>Tulppala et al, 1997</json:string><json:string>Girardi et al, 2004</json:string><json:string>Okuma et al, 2010</json:string><json:string>Oger et al, 1997</json:string><json:string>Exner, 2000</json:string><json:string>Rosove & Brewer, 1992</json:string><json:string>Miyakis et al, 2006</json:string><json:string>Altman, 1991</json:string><json:string>Blank et al, 1991</json:string><json:string>Crowther et al (2003)</json:string><json:string>Ferrara et al, 2003, 2004</json:string><json:string>Branch, 2011</json:string><json:string>Tietjen et al, 1998</json:string><json:string>Cavestro et al, 2011</json:string><json:string>Galli et al (2003a,b)</json:string><json:string>Galli et al.</json:string><json:string>Pengo et al, 2011</json:string><json:string>Tripodi et al, 2001</json:string><json:string>Noble et al, 2005</json:string><json:string>Moore & Savidge, 2004</json:string><json:string>Atsumi et al, 1998b</json:string><json:string>Zoghlami-Rintelen et al, 2005</json:string><json:string>Montalban et al, 1992</json:string><json:string>Oku et al, 2009</json:string><json:string>Galli et al, 2003a,b</json:string><json:string>Naess et al, 2006</json:string><json:string>Stephenson et al, 2004</json:string><json:string>Amengual et al, 1998</json:string><json:string>Bongard et al, 1992</json:string><json:string>Jouhikainen, 1990</json:string><json:string>Schulman et al, 1998</json:string><json:string>Olteanu et al, 2009</json:string><json:string>Derksen et al, 2003</json:string><json:string>Malia et al, 1990</json:string><json:string>RuizIrastorza et al, 2007</json:string><json:string>Rand et al, 2008</json:string><json:string>Lawrie et al, 1999</json:string><json:string>Pierangeli & Harris, 2008</json:string><json:string>Hughes, 2003</json:string><json:string>Cowchock & Reece, 1997</json:string><json:string>Rai et al, 1995</json:string><json:string>Salmon & Girardi, 2004</json:string><json:string>Branch et al, 2001</json:string><json:string>Giannakopoulos et al, 2009</json:string><json:string>Pattison et al, 2000</json:string><json:string>Atsumi et al, 1998a</json:string><json:string>Iorio et al, 2010</json:string><json:string>Giannakopoulos & Krilis, 2009</json:string><json:string>Clyne et al, 1993</json:string><json:string>de Laat et al, 2005</json:string><json:string>Stegnar et al, 1991</json:string><json:string>Pengo et al, 2009</json:string><json:string>Robertson et al, 2006</json:string><json:string>Bertolaccini et al, 2001</json:string><json:string>Kutteh & Ermel, 1996</json:string><json:string>Finazzi et al (2005)</json:string><json:string>Parmar et al, 2009</json:string><json:string>Agar et al, 2010</json:string><json:string>de Groot & Meijers, 2011</json:string><json:string>Laskin et al, 2009</json:string><json:string>Krnic-Barrie et al, 1997</json:string><json:string>de Laat et al, 2004</json:string><json:string>Vila et al, 1994</json:string><json:string>Greaves et al, 2000</json:string><json:string>Buckingham & Chamley, 2009</json:string><json:string>Empson et al, 2005</json:string><json:string>McNeil et al, 1990</json:string><json:string>Sacre et al, 2010</json:string><json:string>Ginsberg et al, 1992</json:string><json:string>de Groot et al, 2005</json:string><json:string>Kearon et al, 2008</json:string><json:string>Moore et al, 2003</json:string><json:string>Ichikawa et al, 1999</json:string><json:string>Galli et al, 1990</json:string><json:string>Greer & Nelson-Piercy, 2005</json:string><json:string>Favaloro, 2007</json:string><json:string>Thom et al, 2003</json:string><json:string>Opatrny et al, 2006</json:string><json:string>Robertson & Greaves, 2006</json:string><json:string>Rand et al, 1998</json:string><json:string>Denis-Magdelaine et al, 1995</json:string><json:string>Edwards et al, 1997</json:string><json:string>Perry et al, 2010</json:string><json:string>Hughes & Khamashta, 2003</json:string><json:string>Erkan et al, 2007</json:string><json:string>Male et al, 2000</json:string><json:string>one study (Moore et al, 2005</json:string><json:string>Miyakis et al (2006)</json:string><json:string>Horowitz et al, 2008</json:string><json:string>Swadzba et al, 2011</json:string><json:string>Bevers et al, 1991</json:string><json:string>Moore & Savidge, 2006</json:string><json:string>Shamonki et al, 2007</json:string><json:string>Sletnes et al, 1992</json:string><json:string>Gardiner et al, 2000</json:string><json:string>Briggs et al, 2008</json:string><json:string>Opatrny et al (2006)</json:string><json:string>Tincani et al, 2004</json:string><json:string>Cervera et al, 2009</json:string><json:string>Chamley et al, 1998</json:string><json:string>Reber et al, 2008</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-JMFFLXHG-G</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - hematology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - immunology</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Hematology</json:string></scopus></categories><publicationDate>2012</publicationDate><copyrightDate>2012</copyrightDate><doi><json:string>10.1111/j.1365-2141.2012.09037.x</json:string></doi><id>77FB09242F766C204AA3EDEAB0546B376358BD0C</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JMFFLXHG-G/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JMFFLXHG-G/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-JMFFLXHG-G/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Guidelines on the investigation and management of antiphospholipid syndrome</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2012 Blackwell Publishing Ltd</licence></availability><date type="published" when="2012-04"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Guidelines on the investigation and management of antiphospholipid syndrome</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">David</forename><surname>Keeling</surname></persName><affiliation><orgName type="division">Oxford Haemophilia and Thrombosis Centre</orgName><orgName type="institution">Churchill Hospital</orgName><address><settlement>Oxford</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Ian</forename><surname>Mackie</surname></persName><affiliation><orgName type="division">Haemostasis Research Unit</orgName>
<orgName type="division">Haematology Department</orgName><orgName type="institution">University College London</orgName><address><settlement>London</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Gary W.</forename><surname>Moore</surname></persName><affiliation><orgName type="division">Centre for Haemostasis and Thrombosis</orgName><orgName type="division">GSTS Pathology</orgName><orgName type="institution">Guy's & St. Thomas’ Hospitals</orgName><address><settlement>London</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Ian A.</forename><surname>Greer</surname></persName><affiliation><orgName type="institution">University of Liverpool</orgName><address><settlement>Liverpool</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Michael</forename><surname>Greaves</surname></persName><affiliation><orgName type="division">School of Medicine & Dentistry</orgName><orgName type="institution">University of Aberdeen</orgName><address><settlement>Aberdeen</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0005"><author><orgName>British Committee for Standards in Haematology</orgName></author><affiliation><orgName type="division">Oxford Haemophilia and Thrombosis Centre</orgName><orgName type="institution">Churchill Hospital</orgName><address><settlement>Oxford</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address><orgName type="division">Haemostasis Research Unit</orgName>
<orgName type="division">Haematology Department</orgName><orgName type="institution">University College London</orgName><address><settlement>London</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address><orgName type="division">Centre for Haemostasis and Thrombosis</orgName><orgName type="division">GSTS Pathology</orgName><orgName type="institution">Guy's & St. Thomas’ Hospitals</orgName><address><settlement>London</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address><orgName type="institution">University of Liverpool</orgName><address><settlement>Liverpool</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address><orgName type="division">School of Medicine & Dentistry</orgName><orgName type="institution">University of Aberdeen</orgName><address><settlement>Aberdeen</settlement><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><idno type="istex">77FB09242F766C204AA3EDEAB0546B376358BD0C</idno><idno type="ark">ark:/67375/WNG-JMFFLXHG-G</idno><idno type="DOI">10.1111/j.1365-2141.2012.09037.x</idno><idno type="unit">BJH9037</idno><idno type="toTypesetVersion">file:BJH.BJH9037.pdf</idno></analytic><monogr><title level="j" type="main">British Journal of Haematology</title><title level="j" type="alt">BRITISH JOURNAL OF HAEMATOLOGY</title><idno type="pISSN">0007-1048</idno><idno type="eISSN">1365-2141</idno><idno type="book-DOI">10.1111/(ISSN)1365-2141</idno><idno type="book-part-DOI">10.1111/bjh.2012.157.issue-1</idno><idno type="product">BJH</idno><imprint><biblScope unit="vol">157</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="47">47</biblScope><biblScope unit="page" to="58">58</biblScope><biblScope unit="page-count">12</biblScope><date type="published" when="2012-04"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><textClass><keywords><term xml:id="bjh9037-kwd-0001">antiphospholipid syndrome</term><term xml:id="bjh9037-kwd-0002">antiphospholid antibodies</term><term xml:id="bjh9037-kwd-0003">thrombophilia</term></keywords><keywords rend="articleCategory"><term>Guideline</term></keywords><keywords rend="tocHeading1"><term>Guideline</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JMFFLXHG-G/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="bjh9037" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2141</doi><issn type="print">0007-1048</issn><issn type="electronic">1365-2141</issn><idGroup><id type="product" value="BJH"></id></idGroup><titleGroup><title sort="BRITISH JOURNAL OF HAEMATOLOGY" type="main">British Journal of Haematology</title><title type="short">Br J Haematol</title></titleGroup></publicationMeta><publicationMeta level="part" position="04101"><doi origin="wiley">10.1111/bjh.2012.157.issue-1</doi><copyright ownership="publisher">Copyright © 2012 Blackwell Publishing Ltd</copyright><numberingGroup><numbering type="journalVolume" number="157">157</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="2012-04">April 2012</coverDate></publicationMeta><publicationMeta level="unit" position="7" status="forIssue" type="article"><doi>10.1111/j.1365-2141.2012.09037.x</doi><idGroup><id type="unit" value="BJH9037"></id></idGroup><countGroup><count number="12" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">Guideline</title><title type="tocHeading1">Guideline</title></titleGroup><copyright ownership="publisher">© 2012 Blackwell Publishing Ltd</copyright><eventGroup><event agent="SPS" date="2012-01-11" type="xmlCreated"></event><event type="publishedOnlineEarlyUnpaginated" date="2012-02-08"></event><event type="firstOnline" date="2012-02-08"></event><event type="publishedOnlineFinalForm" date="2012-03-13"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-27"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.3.7 mode:FullText" date="2015-03-24"></event></eventGroup><numberingGroup><numbering type="pageFirst">47</numbering><numbering type="pageLast">58</numbering></numberingGroup><correspondenceTo><lineatedText><line>Correspondence: David Keeling, c/o BCSH Secretary, British Society for Haematology, 100 White Lion Street, London N1 9PF, UK.</line><line>E‐mail: <email>bcsh@b-s-h.org.uk</email></line></lineatedText></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:BJH.BJH9037.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Guidelines on the investigation and management of antiphospholipid syndrome</title></titleGroup><creators><creator affiliationRef="#bjh9037-aff-0001" corresponding="yes" creatorRole="author" xml:id="bjh9037-cr-0001"><personName><givenNames>David</givenNames> <familyName>Keeling</familyName></personName></creator><creator affiliationRef="#bjh9037-aff-0002" creatorRole="author" xml:id="bjh9037-cr-0002"><personName><givenNames>Ian</givenNames> <familyName>Mackie</familyName></personName></creator><creator affiliationRef="#bjh9037-aff-0003" creatorRole="author" xml:id="bjh9037-cr-0003"><personName><givenNames>Gary W.</givenNames> <familyName>Moore</familyName></personName></creator><creator affiliationRef="#bjh9037-aff-0004" creatorRole="author" xml:id="bjh9037-cr-0004"><personName><givenNames>Ian A.</givenNames> <familyName>Greer</familyName></personName></creator><creator affiliationRef="#bjh9037-aff-0005" creatorRole="author" xml:id="bjh9037-cr-0005"><personName><givenNames>Michael</givenNames> <familyName>Greaves</familyName></personName></creator><creator creatorRole="author" xml:id="bjh9037-cr-0006"><groupName>British Committee for Standards in Haematology</groupName></creator></creators><affiliationGroup><affiliation countryCode="GB" type="organization" xml:id="bjh9037-aff-0001"><orgDiv>Oxford Haemophilia and Thrombosis Centre</orgDiv><orgName>Churchill Hospital</orgName><address><city>Oxford</city><country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="bjh9037-aff-0002"><orgDiv>Haemostasis Research Unit</orgDiv> <orgDiv>Haematology Department</orgDiv><orgName>University College London</orgName><address><city>London</city><country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="bjh9037-aff-0003"><orgDiv>Centre for Haemostasis and Thrombosis</orgDiv><orgDiv>GSTS Pathology</orgDiv><orgName>Guy's & St. Thomas’ Hospitals</orgName><address><city>London</city><country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="bjh9037-aff-0004"><orgName>University of Liverpool</orgName><address><city>Liverpool</city><country>UK</country></address></affiliation><affiliation countryCode="GB" type="organization" xml:id="bjh9037-aff-0005"><orgDiv>School of Medicine & Dentistry</orgDiv><orgName>University of Aberdeen</orgName><address><city>Aberdeen</city><country>UK</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="bjh9037-kwd-0001">antiphospholipid syndrome</keyword><keyword xml:id="bjh9037-kwd-0002">antiphospholid antibodies</keyword><keyword xml:id="bjh9037-kwd-0003">thrombophilia</keyword></keywordGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Guidelines on the investigation and management of antiphospholipid syndrome</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Guidelines on the investigation and management of antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">David</namePart><namePart type="family">Keeling</namePart><affiliation>Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford, UK</affiliation><affiliation>Correspondence: David Keeling, c/o BCSH Secretary, British Society for Haematology, 100 White Lion Street, London N1 9PF, UK.E‐mail:</affiliation><affiliation>E-mail: bcsh@b-s-h.org.uk</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ian</namePart><namePart type="family">Mackie</namePart><affiliation>Haemostasis Research Unit, Haematology Department, University College London, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gary W.</namePart><namePart type="family">Moore</namePart><affiliation>Centre for Haemostasis and Thrombosis, GSTS Pathology, Guy's & St. Thomas’ Hospitals, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ian A.</namePart><namePart type="family">Greer</namePart><affiliation>University of Liverpool, Liverpool, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michael</namePart><namePart type="family">Greaves</namePart><affiliation>School of Medicine & Dentistry, University of Aberdeen, Aberdeen, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="corporate"><namePart>British Committee for Standards in Haematology</namePart></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2012-04</dateIssued><dateCreated encoding="w3cdtf">2012-01-11</dateCreated><copyrightDate encoding="w3cdtf">2012</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><subject><genre>keywords</genre><topic>antiphospholipid syndrome</topic><topic>antiphospholid antibodies</topic><topic>thrombophilia</topic></subject><relatedItem type="host"><titleInfo><title>British Journal of Haematology</title></titleInfo><titleInfo type="abbreviated"><title>Br J Haematol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Guideline</topic><topic>Guideline</topic></subject><identifier type="ISSN">0007-1048</identifier><identifier type="eISSN">1365-2141</identifier><identifier type="DOI">10.1111/(ISSN)1365-2141</identifier><identifier type="PublisherID">BJH</identifier><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>47</start><end>58</end><total>12</total></extent></part></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0001"><titleInfo><title>β2‐Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Agar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.M.</namePart><namePart type="family">van Os</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Morgelin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.R.</namePart><namePart type="family">Sprenger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.A.</namePart><namePart type="family">Marquart</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.T.</namePart><namePart type="family">Urbanus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Meijers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Agar, C., van Os, G.M., Morgelin, M., Sprenger, R.R., Marquart, J.A., Urbanus, R.T., Derksen, R.H., Meijers, J.C. & de Groot, P.G. (2010) β2‐Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood, 116, 1336–1343.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>116</number></detail><extent unit="pages"><start>1336</start><end>1343</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>116</number></detail><extent unit="pages"><start>1336</start><end>1343</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0002"><titleInfo><title>Altman, D.G. (1991) Practical Statistics for Medical Research. Chapman & Hall, London.</title></titleInfo><note type="citation/reference">Altman, D.G. (1991) Practical Statistics for Medical Research. Chapman & Hall, London.</note><name type="personal"><namePart type="given">D.G.</namePart><namePart type="family">Altman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Chapman & Hall</publisher><place><placeTerm type="text">London</placeTerm></place></originInfo><part><date>1991</date></part></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0003"><titleInfo><title>The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Amengual</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Amengual, O., Atsumi, T., Khamashta, M.A. & Hughes, G.R. (1998) The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thrombosis and Haemostasis, 79, 276–281.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>276</start><end>281</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>276</start><end>281</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0004"><titleInfo><title>Binding of anticardiolipin antibodies to protein C via beta2‐glycoprotein I (beta2‐GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system</title></titleInfo><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Amengual</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Donohoe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Mackie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Ichikawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Koike</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Atsumi, T., Khamashta, M.A., Amengual, O., Donohoe, S., Mackie, I., Ichikawa, K., Koike, T. & Hughes, G.R. (1998a) Binding of anticardiolipin antibodies to protein C via beta2‐glycoprotein I (beta2‐GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Clinical and Experimental Immunology, 112, 325–333.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>325</start><end>333</end></extent></part><relatedItem type="host"><titleInfo><title>Clinical and Experimental Immunology</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>325</start><end>333</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0005"><titleInfo><title>Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Andujar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Leandro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Amengual</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.R.</namePart><namePart type="family">Ames</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Atsumi, T., Khamashta, M.A., Andujar, C., Leandro, M.J., Amengual, O., Ames, P.R. & Hughes, G.R. (1998b) Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. Journal of Rheumatology, 25, 69–73.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>69</start><end>73</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Rheumatology</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>69</start><end>73</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0006"><titleInfo><title>The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus</title></titleInfo><name type="personal"><namePart type="given">M.L.</namePart><namePart type="family">Bertolaccini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Escudero Contreras</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bertolaccini, M.L., Atsumi, T., Escudero Contreras, A., Khamashta, M.A. & Hughes, G.R. (2001) The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Journal of Rheumatology, 28, 2637–2643.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>2637</start><end>2643</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Rheumatology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>2637</start><end>2643</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0007"><titleInfo><title>Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid‐bound human prothrombin</title></titleInfo><name type="personal"><namePart type="given">E.M.</namePart><namePart type="family">Bevers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Barbui</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Comfurius</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.F.</namePart><namePart type="family">Zwaal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bevers, E.M., Galli, M., Barbui, T., Comfurius, P. & Zwaal, R.F. (1991) Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid‐bound human prothrombin. Thrombosis and Haemostasis, 66, 629–632.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>629</start><end>632</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>629</start><end>632</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0008"><titleInfo><title>Induction of anti‐phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti‐cardiolipin antibodies</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Blank</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Cohen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Toder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Shoenfeld</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Blank, M., Cohen, J., Toder, V. & Shoenfeld, Y. (1991) Induction of anti‐phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti‐cardiolipin antibodies. Proceedings of the National Academy of Sciences of the United States of America, 88, 3069–3073.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>3069</start><end>3073</end></extent></part><relatedItem type="host"><titleInfo><title>Proceedings of the National Academy of Sciences of the United States of America</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>3069</start><end>3073</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0009"><titleInfo><title>Anticardiolipin antibodies in acute venous thromboembolism [letter]</title></titleInfo><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Bongard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Reber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Bounameaux</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">de Moerloose</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bongard, O., Reber, G., Bounameaux, H. & de Moerloose, P. (1992) Anticardiolipin antibodies in acute venous thromboembolism [letter]. Thrombosis and Haemostasis, 67, 724.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>724</start></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>724</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0010"><titleInfo><title>Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010</title></titleInfo><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Branch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Branch, W. (2011) Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010. Lupus, 20, 158–164.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>158</start><end>164</end></extent></part><relatedItem type="host"><titleInfo><title>Lupus</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>158</start><end>164</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0011"><titleInfo><title>Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis</title></titleInfo><name type="personal"><namePart type="given">D.W.</namePart><namePart type="family">Branch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.M.</namePart><namePart type="family">Rodgers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Branch, D.W. & Rodgers, G.M. (1993) Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. American Journal of Obstetrics and Gynecology, 168, 206–210.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>168</number></detail><extent unit="pages"><start>206</start><end>210</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Obstetrics and Gynecology</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>168</number></detail><extent unit="pages"><start>206</start><end>210</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0012"><titleInfo><title>Antiphospholipid antibodies in women at risk for preeclampsia</title></titleInfo><name type="personal"><namePart type="given">D.W.</namePart><namePart type="family">Branch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.F.</namePart><namePart type="family">Porter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Rittenhouse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Caritis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Sibai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Hogg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.D.</namePart><namePart type="family">Lindheimer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Klebanoff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">MacPherson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.P.</namePart><namePart type="family">VanDorsten</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Landon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Paul</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Miodovnik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Meis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Thurnau</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Branch, D.W., Porter, T.F., Rittenhouse, L., Caritis, S., Sibai, B., Hogg, B., Lindheimer, M.D., Klebanoff, M., MacPherson, C., VanDorsten, J.P., Landon, M., Paul, R., Miodovnik, M., Meis, P. & Thurnau, G. (2001) Antiphospholipid antibodies in women at risk for preeclampsia. American Journal of Obstetrics and Gynecology, 184, 825–832; discussion 832–824.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>184</number></detail><extent unit="pages"><start>825</start><end>832</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Obstetrics and Gynecology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>184</number></detail><extent unit="pages"><start>825</start><end>832</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0013"><titleInfo><title>Guidelines for point‐of‐care testing: haematology</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Briggs</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Guthrie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Hyde</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Mackie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Parker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Popek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Porter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Stephens</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Briggs, C., Guthrie, D., Hyde, K., Mackie, I., Parker, N., Popek, M., Porter, N. & Stephens, C. (2008) Guidelines for point‐of‐care testing: haematology. British Journal of Haematology, 142, 904–915.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>142</number></detail><extent unit="pages"><start>904</start><end>915</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal of Haematology</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>142</number></detail><extent unit="pages"><start>904</start><end>915</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0014"><titleInfo><title>A critical assessment of the role of antiphospholipid antibodies in infertility</title></titleInfo><name type="personal"><namePart type="given">K.L.</namePart><namePart type="family">Buckingham</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.W.</namePart><namePart type="family">Chamley</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Buckingham, K.L. & Chamley, L.W. (2009) A critical assessment of the role of antiphospholipid antibodies in infertility. Journal of Reproductive Immunology, 80, 132–145.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>132</start><end>145</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Reproductive Immunology</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>132</start><end>145</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0015"><titleInfo><title>Migraineurs show a high prevalence of antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Cavestro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Micca</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Molinari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Bazzan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.I.P.</namePart><namePart type="family">C</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Aloi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Pedemonte</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Iannini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.C.</namePart><namePart type="family">Frigeri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Roccatello</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cavestro, C., Micca, G., Molinari, F., Bazzan, M., C, D.I.P., Aloi, R., Pedemonte, E., Iannini, R., Frigeri, M.C. & Roccatello, D. (2011) Migraineurs show a high prevalence of antiphospholipid antibodies. Journal of Thrombosis and Haemostasis, 9, 1350–1354.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1350</start><end>1354</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1350</start><end>1354</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0016"><titleInfo><title>Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Cervera</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Piette</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Font</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Shoenfeld</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.T.</namePart><namePart type="family">Camps</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Jacobsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Lakos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tincani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Kontopoulou‐Griva</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galeazzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Meroni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Gromnica‐Ihle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Baleva</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Mosca</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Bombardieri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Houssiau</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Gris</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Quere</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Hachulla</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Vasconcelos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Roch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Fernandez‐Nebro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.C.</namePart><namePart type="family">Boffa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Ingelmo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., Galeazzi, M., Meroni, P.L., Derksen, R.H., de Groot, P.G., Gromnica‐Ihle, E., Baleva, M., Mosca, M., Bombardieri, S., Houssiau, F., Gris, J.C., Quere, I., Hachulla, E., Vasconcelos, C., Roch, B., Fernandez‐Nebro, A., Boffa, M.C., Hughes, G.R. & Ingelmo, M. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis and Rheumatism, 46, 1019–1027.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>1019</start><end>1027</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis and Rheumatism</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>1019</start><end>1027</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0017"><titleInfo><title>Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Cervera</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Bucciarelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Plasin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.A.</namePart><namePart type="family">Gomez‐Puerta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Plaza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Pons‐Estel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Shoenfeld</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Ingelmo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Espinos</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cervera, R., Bucciarelli, S., Plasin, M.A., Gomez‐Puerta, J.A., Plaza, J., Pons‐Estel, G., Shoenfeld, Y., Ingelmo, M. & Espinos, G. (2009) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. Journal of Autoimmunity, 32, 240–245.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>240</start><end>245</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Autoimmunity</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>240</start><end>245</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0018"><titleInfo><title>Action of anticardiolipin and antibodies to beta2‐glycoprotein‐I on trophoblast proliferation as a mechanism for fetal death</title></titleInfo><name type="personal"><namePart type="given">L.W.</namePart><namePart type="family">Chamley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.M.</namePart><namePart type="family">Duncalf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.D.</namePart><namePart type="family">Mitchell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.M.</namePart><namePart type="family">Johnson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chamley, L.W., Duncalf, A.M., Mitchell, M.D. & Johnson, P.M. (1998) Action of anticardiolipin and antibodies to beta2‐glycoprotein‐I on trophoblast proliferation as a mechanism for fetal death. Lancet, 352, 1037–1038.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>352</number></detail><extent unit="pages"><start>1037</start><end>1038</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>352</number></detail><extent unit="pages"><start>1037</start><end>1038</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0019"><titleInfo><title>The lupus anticoagulant. High incidence of ‘negative’ mixing studies in a human immunodeficiency virus‐positive population</title></titleInfo><name type="personal"><namePart type="given">L.P.</namePart><namePart type="family">Clyne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Yen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.S.</namePart><namePart type="family">Kriz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.G.</namePart><namePart type="family">Breitenstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Clyne, L.P., Yen, Y., Kriz, N.S. & Breitenstein, M.G. (1993) The lupus anticoagulant. High incidence of ‘negative’ mixing studies in a human immunodeficiency virus‐positive population. Archives of Pathology and Laboratory Medicine, 117, 595–601.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>595</start><end>601</end></extent></part><relatedItem type="host"><titleInfo><title>Archives of Pathology and Laboratory Medicine</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>595</start><end>601</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0020"><titleInfo><title>Do low‐risk pregnant women with antiphospholipid antibodies need to be treated? Organizang Group of the Antiphospholipid Antibody Treatment Trial</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Cowchock</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.A.</namePart><namePart type="family">Reece</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cowchock, S. & Reece, E.A. (1997) Do low‐risk pregnant women with antiphospholipid antibodies need to be treated? Organizang Group of the Antiphospholipid Antibody Treatment Trial. American Journal of Obstetrics and Gynecology, 176, 1099–1100.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>176</number></detail><extent unit="pages"><start>1099</start><end>1100</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Obstetrics and Gynecology</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>176</number></detail><extent unit="pages"><start>1099</start><end>1100</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0021"><titleInfo><title>A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome</title></titleInfo><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Crowther</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.S.</namePart><namePart type="family">Ginsberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Julian</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Denburg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Hirsh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Douketis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Laskin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Fortin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Kearon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Clarke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Geerts</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Forgie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Green</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Costantini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Yacura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Wilson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Gent</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Kovacs</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M. & Kovacs, M.J. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. New England Journal of Medicine, 349, 1133–1138.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>349</number></detail><extent unit="pages"><start>1133</start><end>1138</end></extent></part><relatedItem type="host"><titleInfo><title>New England Journal of Medicine</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>349</number></detail><extent unit="pages"><start>1133</start><end>1138</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0022"><titleInfo><title>β2‐Glycoprotein I: evolution, structure and function</title></titleInfo><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Meijers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">de Groot, P.G. & Meijers, J.C. (2011) β2‐Glycoprotein I: evolution, structure and function. Journal of Thrombosis and Haemostasis, 9, 1275–1284.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1275</start><end>1284</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1275</start><end>1284</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0023"><titleInfo><title>Lupus anticoagulants and the risk of a first episode of deep venous thrombosis</title></titleInfo><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Lutters</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Lisman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Meijers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.R.</namePart><namePart type="family">Rosendaal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">de Groot, P.G., Lutters, B., Derksen, R.H., Lisman, T., Meijers, J.C. & Rosendaal, F.R. (2005) Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 1993–1997.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>1993</start><end>1997</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>1993</start><end>1997</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0024"><titleInfo><title>β2‐glycoprotein I‐dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">H.B.</namePart><namePart type="family">de Laat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.T.</namePart><namePart type="family">Urbanus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Roest</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">de Laat, H.B., Derksen, R.H., Urbanus, R.T., Roest, M. & de Groot, P.G. (2004) β2‐glycoprotein I‐dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood, 104, 3598–3602.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>3598</start><end>3602</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>3598</start><end>3602</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0025"><titleInfo><title>IgG antibodies that recognize epitope Gly40‐Arg43 in domain I of beta 2‐glycoprotein I cause LAC, and their presence correlates strongly with thrombosis</title></titleInfo><name type="personal"><namePart type="given">B.</namePart><namePart type="family">de Laat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.T.</namePart><namePart type="family">Urbanus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">de Laat, B., Derksen, R.H., Urbanus, R.T. & de Groot, P.G. (2005) IgG antibodies that recognize epitope Gly40‐Arg43 in domain I of beta 2‐glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood, 105, 1540–1545.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>105</number></detail><extent unit="pages"><start>1540</start><end>1545</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>105</number></detail><extent unit="pages"><start>1540</start><end>1545</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0026"><titleInfo><title>Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Denis‐Magdelaine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Flahault</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Verdy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Denis‐Magdelaine, A., Flahault, A. & Verdy, E. (1995) Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants. Haemostasis, 25, 98–105.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>98</start><end>105</end></extent></part><relatedItem type="host"><titleInfo><title>Haemostasis</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>98</start><end>105</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0027"><titleInfo><title>Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.J.</namePart><namePart type="family">Kappelle</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Derksen, R.H., de Groot, P.G. & Kappelle, L.J. (2003) Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome. Neurology, 61, 111–114.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>111</start><end>114</end></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>111</start><end>114</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0028"><titleInfo><title>Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice</title></titleInfo><name type="personal"><namePart type="given">M.H.</namePart><namePart type="family">Edwards</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Pierangeli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X.</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.H.</namePart><namePart type="family">Barker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.N.</namePart><namePart type="family">Harris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Edwards, M.H., Pierangeli, S., Liu, X., Barker, J.H., Anderson, G. & Harris, E.N. (1997) Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation, 96, 4380–4384.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>4380</start><end>4384</end></extent></part><relatedItem type="host"><titleInfo><title>Circulation</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>4380</start><end>4384</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0029"><titleInfo><title>Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant</title></titleInfo><name type="personal"><namePart type="given">M.B.</namePart><namePart type="family">Empson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Lassere</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Craig</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.R.</namePart><namePart type="family">Scott</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Empson, M.B., Lassere, M., Craig, J.C. & Scott, J.R. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002859. DOI: 10.1002/14651858.CD002859.pub2.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>Issue 2. Art. No.:</number></detail><extent unit="pages"><start>CD002859</start></extent></part><relatedItem type="host"><titleInfo><title>Cochrane Database of Systematic Reviews</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>Issue 2. Art. No.:</number></detail><extent unit="pages"><start>CD002859</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0030"><titleInfo><title>Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody‐positive individuals</title></titleInfo><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Erkan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Harrison</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Levy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Peterson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Petri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Sammaritano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Unalp‐Arida</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Vilela</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Yazici</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.D.</namePart><namePart type="family">Lockshin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Erkan, D., Harrison, M.J., Levy, R., Peterson, M., Petri, M., Sammaritano, L., Unalp‐Arida, A., Vilela, V., Yazici, Y. & Lockshin, M.D. (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody‐positive individuals. Arthritis and Rheumatism, 56, 2382–2391.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>2382</start><end>2391</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis and Rheumatism</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>2382</start><end>2391</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0031"><titleInfo><title>Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Espinola</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.S.</namePart><namePart type="family">Pierangeli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.E.</namePart><namePart type="family">Gharavi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.N.</namePart><namePart type="family">Harris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Espinola, R.G., Pierangeli, S.S., Gharavi, A.E. & Harris, E.N. (2002) Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thrombosis and Haemostasis, 87, 518–522.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>518</start><end>522</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>518</start><end>522</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0032"><titleInfo><title>Conceptions and misconceptions in testing for lupus anticoagulants</title></titleInfo><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Exner</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Exner, T. (2000) Conceptions and misconceptions in testing for lupus anticoagulants. Journal of Autoimmunity, 15, 179–183.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>179</start><end>183</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Autoimmunity</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>179</start><end>183</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0033"><titleInfo><title>Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment</title></titleInfo><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Farquharson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Quenby</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Farquharson, R.G., Quenby, S. & Greaves, M. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology, 100, 408–413.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>408</start><end>413</end></extent></part><relatedItem type="host"><titleInfo><title>Obstetrics and Gynecology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>408</start><end>413</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0034"><titleInfo><title>Preanalytical variables in coagulation testing</title></titleInfo><name type="personal"><namePart type="given">E.J.</namePart><namePart type="family">Favaloro</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Favaloro, E.J. (2007) Preanalytical variables in coagulation testing. Blood Coagulation and Fibrinolysis, 18, 86–89.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>86</start><end>89</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Coagulation and Fibrinolysis</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>86</start><end>89</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0035"><titleInfo><title>Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model</title></titleInfo><name type="personal"><namePart type="given">D.E.</namePart><namePart type="family">Ferrara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X.</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Espinola</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Meroni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Abukhalaf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.N.</namePart><namePart type="family">Harris</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.S.</namePart><namePart type="family">Pierangeli</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ferrara, D.E., Liu, X., Espinola, R.G., Meroni, P.L., Abukhalaf, I., Harris, E.N. & Pierangeli, S.S. (2003) Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis and Rheumatism, 48, 3272–3279.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>3272</start><end>3279</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis and Rheumatism</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>3272</start><end>3279</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0036"><titleInfo><title>Fluvastatin inhibits up‐regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells</title></titleInfo><name type="personal"><namePart type="given">D.E.</namePart><namePart type="family">Ferrara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Swerlick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Casper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Meroni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.E.</namePart><namePart type="family">Vega‐Ostertag</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.N.</namePart><namePart type="family">Harris</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.S.</namePart><namePart type="family">Pierangeli</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ferrara, D.E., Swerlick, R., Casper, K., Meroni, P.L., Vega‐Ostertag, M.E., Harris, E.N. & Pierangeli, S.S. (2004) Fluvastatin inhibits up‐regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. Journal of Thrombosis and Haemostasis, 2, 1558–1563.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>1558</start><end>1563</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>1558</start><end>1563</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0037"><titleInfo><title>A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)</title></titleInfo><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Finazzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Marchioli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Brancaccio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Schinco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Wisloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Musial</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Baudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Berrettini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Testa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">D'Angelo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Tognoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Barbui</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J., Baudo, F., Berrettini, M., Testa, S., D'Angelo, A., Tognoni, G. & Barbui, T. (2005) A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis, 3, 848–853.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>848</start><end>853</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>848</start><end>853</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0038"><titleInfo><title>Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Comfurius</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Maassen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.C.</namePart><namePart type="family">Hemker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.H.</namePart><namePart type="family">de Baets</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.J.</namePart><namePart type="family">van Breda Vriesman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Barbui</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.F.</namePart><namePart type="family">Zwaal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.M.</namePart><namePart type="family">Bevers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., de Baets, M.H., van Breda Vriesman, P.J., Barbui, T., Zwaal, R.F. & Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor [see comments]. Lancet, 335, 1544–1547.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>335</number></detail><extent unit="pages"><start>1544</start><end>1547</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>335</number></detail><extent unit="pages"><start>1544</start><end>1547</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0039"><titleInfo><title>Anti‐beta 2‐glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Luciani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Bertolini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Barbui</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Galli, M., Luciani, D., Bertolini, G. & Barbui, T. (2003a) Anti‐beta 2‐glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood, 102, 2717–2723.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>102</number></detail><extent unit="pages"><start>2717</start><end>2723</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>102</number></detail><extent unit="pages"><start>2717</start><end>2723</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0040"><titleInfo><title>Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Luciani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Bertolini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Barbui</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Galli, M., Luciani, D., Bertolini, G. & Barbui, T. (2003b) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood, 101, 1827–1832.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><extent unit="pages"><start>1827</start><end>1832</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><extent unit="pages"><start>1827</start><end>1832</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0041"><titleInfo><title>Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Borrelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.M.</namePart><namePart type="family">Jacobsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.M.</namePart><namePart type="family">Marfisi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Finazzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Marchioli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Wisloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Marziali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Morboeuf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Barbui</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Galli, M., Borrelli, G., Jacobsen, E.M., Marfisi, R.M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O. & Barbui, T. (2007) Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood, 110, 1178–1183.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>1178</start><end>1183</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>1178</start><end>1183</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0042"><titleInfo><title>The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Gardiner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.J.</namePart><namePart type="family">Mackie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Malia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.W.</namePart><namePart type="family">Jones</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Winter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Leeming</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.A.</namePart><namePart type="family">Taberner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.J.</namePart><namePart type="family">Machin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gardiner, C., Mackie, I.J., Malia, R.G., Jones, D.W., Winter, M., Leeming, D., Taberner, D.A., Machin, S.J. & Greaves, M. (2000) The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant. British Journal of Haematology, 111, 1230–1235.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>1230</start><end>1235</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal of Haematology</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>1230</start><end>1235</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0043"><titleInfo><title>How I treat the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Giannakopoulos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.A.</namePart><namePart type="family">Krilis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Giannakopoulos, B. & Krilis, S.A. (2009) How I treat the antiphospholipid syndrome. Blood, 114, 2020–2030.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>2020</start><end>2030</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>2020</start><end>2030</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0044"><titleInfo><title>Current concepts on the pathogenesis of the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Giannakopoulos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Passam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Rahgozar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.A.</namePart><namePart type="family">Krilis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Giannakopoulos, B., Passam, F., Rahgozar, S. & Krilis, S.A. (2007) Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood, 109, 422–430.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>422</start><end>430</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>422</start><end>430</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0045"><titleInfo><title>How we diagnose the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Giannakopoulos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Passam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Ioannou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.A.</namePart><namePart type="family">Krilis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Giannakopoulos, B., Passam, F., Ioannou, Y. & Krilis, S.A. (2009) How we diagnose the antiphospholipid syndrome. Blood, 113, 985–994.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>113</number></detail><extent unit="pages"><start>985</start><end>994</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>113</number></detail><extent unit="pages"><start>985</start><end>994</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0046"><titleInfo><title>Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross‐sectional study</title></titleInfo><name type="personal"><namePart type="given">J.S.</namePart><namePart type="family">Ginsberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Brill‐Edwards</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Johnston</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.A.</namePart><namePart type="family">Denburg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Andrew</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.F.</namePart><namePart type="family">Burrows</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Bensen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Cividino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.A.</namePart><namePart type="family">Long</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ginsberg, J.S., Brill‐Edwards, P., Johnston, M., Denburg, J.A., Andrew, M., Burrows, R.F., Bensen, W., Cividino, A. & Long, A.A. (1992) Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross‐sectional study. Blood, 80, 975–980.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>975</start><end>980</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>975</start><end>980</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0047"><titleInfo><title>Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis</title></titleInfo><name type="personal"><namePart type="given">K.S.</namePart><namePart type="family">Ginsburg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.H.</namePart><namePart type="family">Liang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Newcomer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.Z.</namePart><namePart type="family">Goldhaber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.H.</namePart><namePart type="family">Schur</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.H.</namePart><namePart type="family">Hennekens</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Stampfer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ginsburg, K.S., Liang, M.H., Newcomer, L., Goldhaber, S.Z., Schur, P.H., Hennekens, C.H. & Stampfer, M.J. (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis [see comments]. Annals of Internal Medicine, 117, 997–1002.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>997</start><end>1002</end></extent></part><relatedItem type="host"><titleInfo><title>Annals of Internal Medicine</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>997</start><end>1002</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0048"><titleInfo><title>Heparin prevents antiphospholipid antibody‐induced fetal loss by inhibiting complement activation</title></titleInfo><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Girardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Redecha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.E.</namePart><namePart type="family">Salmon</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Girardi, G., Redecha, P. & Salmon, J.E. (2004) Heparin prevents antiphospholipid antibody‐induced fetal loss by inhibiting complement activation. Nature Medicine, 10, 1222–1226.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>1222</start><end>1226</end></extent></part><relatedItem type="host"><titleInfo><title>Nature Medicine</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>1222</start><end>1226</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0049"><titleInfo><title>Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals</title></titleInfo><name type="personal"><namePart type="given">J.A.</namePart><namePart type="family">Giron‐Gonzalez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Garcia del Rio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Rodriguez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Rodriguez‐Martorell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Serrano</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Giron‐Gonzalez, J.A., Garcia del Rio, E., Rodriguez, C., Rodriguez‐Martorell, J. & Serrano, A. (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. Journal of Rheumatology, 31, 1560–1567.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1560</start><end>1567</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Rheumatology</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1560</start><end>1567</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0050"><titleInfo><title>Guidelines on the investigation and management of the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Cohen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">MacHin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Mackie</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Greaves, M., Cohen, H., MacHin, S. & Mackie, I. (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. British Journal Haematology, 109, 704–715.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>704</start><end>715</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal Haematology</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>704</start><end>715</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0051"><titleInfo><title>Low‐molecular‐weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy</title></titleInfo><name type="personal"><namePart type="given">I.A.</namePart><namePart type="family">Greer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Nelson‐Piercy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Greer, I.A. & Nelson‐Piercy, C. (2005) Low‐molecular‐weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood, 106, 401–407.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>106</number></detail><extent unit="pages"><start>401</start><end>407</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>106</number></detail><extent unit="pages"><start>401</start><end>407</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0052"><titleInfo><title>Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics</title></titleInfo><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Heinzlef</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Weill</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Johanet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Sazdovitch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Caillat‐Zucman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Tournier‐Lasserve</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Roullet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heinzlef, O., Weill, B., Johanet, C., Sazdovitch, V., Caillat‐Zucman, S., Tournier‐Lasserve, E. & Roullet, E. (2002) Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. Journal of Neurology, Neurosurgery and Psychiatry, 72, 647–649.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>647</start><end>649</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Neurology, Neurosurgery and Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>647</start><end>649</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0053"><titleInfo><title>Horowitz, G.L., Altaie, S., Boyd, J.C., Ceriotti, F., Garg, U., Horn, P., Pesce, A., Sine, H.E. & Zakowski, J. (2008) Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline – Third Edition. CLSI document C28‐A3c. Clinical and Laboratory Standards Institute, Wayne, PA, USA.</title></titleInfo><note type="citation/reference">Horowitz, G.L., Altaie, S., Boyd, J.C., Ceriotti, F., Garg, U., Horn, P., Pesce, A., Sine, H.E. & Zakowski, J. (2008) Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline – Third Edition. CLSI document C28‐A3c. Clinical and Laboratory Standards Institute, Wayne, PA, USA.</note><name type="personal"><namePart type="given">G.L.</namePart><namePart type="family">Horowitz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Altaie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Boyd</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Ceriotti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">U.</namePart><namePart type="family">Garg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Horn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Pesce</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.E.</namePart><namePart type="family">Sine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Zakowski</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Clinical and Laboratory Standards Institute</publisher><place><placeTerm type="text">Wayne, PA, USA</placeTerm></place></originInfo><part><date>2008</date></part></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0054"><titleInfo><title>Migraine, memory loss, and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes’) syndrome</title></titleInfo><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hughes, G.R. (2003) Migraine, memory loss, and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes’) syndrome. Postgraduate Medical Journal, 79, 81–83.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>81</start><end>83</end></extent></part><relatedItem type="host"><titleInfo><title>Postgraduate Medical Journal</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>81</start><end>83</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0055"><titleInfo><title>Seronegative antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hughes, G.R. & Khamashta, M.A. (2003) Seronegative antiphospholipid syndrome. Annals of the Rheumatic Diseases, 62, 1127.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>1127</start></extent></part><relatedItem type="host"><titleInfo><title>Annals of the Rheumatic Diseases</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>1127</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0056"><titleInfo><title>A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2‐glycoprotein I‐dependent anticardiolipin and anti‐beta2‐glycoprotein I antibodies</title></titleInfo><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Ichikawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tsutsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Matsuura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Kobayashi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Koike</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ichikawa, K., Tsutsumi, A., Atsumi, T., Matsuura, E., Kobayashi, S., Hughes, G.R., Khamashta, M.A. & Koike, T. (1999) A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2‐glycoprotein I‐dependent anticardiolipin and anti‐beta2‐glycoprotein I antibodies. Arthritis and Rheumatism, 42, 2461–2470.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>2461</start><end>2470</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis and Rheumatism</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>2461</start><end>2470</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0057"><titleInfo><title>Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Iorio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Kearon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Filippucci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Marcucci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Macura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Pengo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Siragusa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Palareti</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iorio, A., Kearon, C., Filippucci, E., Marcucci, M., Macura, A., Pengo, V., Siragusa, S. & Palareti, G. (2010) Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Archives of Internal Medicine, 170, 1710–1716.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>170</number></detail><extent unit="pages"><start>1710</start><end>1716</end></extent></part><relatedItem type="host"><titleInfo><title>Archives of Internal Medicine</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>170</number></detail><extent unit="pages"><start>1710</start><end>1716</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0058"><titleInfo><title>Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy</title></titleInfo><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Jouhikainen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jouhikainen, T. (1990) Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy. Blood Coagulation and Fibrinolysis, 1, 627–632.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>627</start><end>632</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Coagulation and Fibrinolysis</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>627</start><end>632</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0059"><titleInfo><title>Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition)</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Kearon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.R.</namePart><namePart type="family">Kahn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Agnelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Goldhaber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.E.</namePart><namePart type="family">Raskob</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.J.</namePart><namePart type="family">Comerota</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kearon, C., Kahn, S.R., Agnelli, G., Goldhaber, S., Raskob, G.E. & Comerota, A.J. (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition). Chest, 133, 454S–545S.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>454S</start><end>545S</end></extent></part><relatedItem type="host"><titleInfo><title>Chest</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>454S</start><end>545S</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0060"><titleInfo><title>The management of thrombosis in the antiphospholipid‐antibody syndrome</title></titleInfo><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Cuadrado</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Mujic</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.A.</namePart><namePart type="family">Taub</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.J.</namePart><namePart type="family">Hunt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. & Hughes, G.R. (1995) The management of thrombosis in the antiphospholipid‐antibody syndrome [see comments]. New England Journal of Medicine, 332, 993–997.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>332</number></detail><extent unit="pages"><start>993</start><end>997</end></extent></part><relatedItem type="host"><titleInfo><title>New England Journal of Medicine</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>332</number></detail><extent unit="pages"><start>993</start><end>997</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0061"><titleInfo><title>A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Krnic‐Barrie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.R.</namePart><namePart type="family">O'Connor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.W.</namePart><namePart type="family">Looney</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.S.</namePart><namePart type="family">Pierangeli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.N.</namePart><namePart type="family">Harris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Krnic‐Barrie, S., O'Connor, C.R., Looney, S.W., Pierangeli, S.S. & Harris, E.N. (1997) A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Archives of Internal Medicine, 157, 2101–2108.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>2101</start><end>2108</end></extent></part><relatedItem type="host"><titleInfo><title>Archives of Internal Medicine</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>2101</start><end>2108</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0062"><titleInfo><title>A clinical trial for the treatment of antiphospholipid antibody‐associated recurrent pregnancy loss with lower dose heparin and aspirin</title></titleInfo><name type="personal"><namePart type="given">W.H.</namePart><namePart type="family">Kutteh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.D.</namePart><namePart type="family">Ermel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kutteh, W.H. & Ermel, L.D. (1996) A clinical trial for the treatment of antiphospholipid antibody‐associated recurrent pregnancy loss with lower dose heparin and aspirin. American Journal of Reproductive Immunology, 35, 402–407.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>402</start><end>407</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Reproductive Immunology</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>402</start><end>407</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0063"><titleInfo><title>Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss</title></titleInfo><name type="personal"><namePart type="given">C.A.</namePart><namePart type="family">Laskin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Bombardier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.E.</namePart><namePart type="family">Hannah</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.P.</namePart><namePart type="family">Mandel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.W.</namePart><namePart type="family">Ritchie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Farewell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Farine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Spitzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Fielding</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.A.</namePart><namePart type="family">Soloninka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Yeung</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Laskin, C.A., Bombardier, C., Hannah, M.E., Mandel, F.P., Ritchie, J.W., Farewell, V., Farine, D., Spitzer, K., Fielding, L., Soloninka, C.A. & Yeung, M. (1997) Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. New England Journal of Medicine, 337, 148–153.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>337</number></detail><extent unit="pages"><start>148</start><end>153</end></extent></part><relatedItem type="host"><titleInfo><title>New England Journal of Medicine</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>337</number></detail><extent unit="pages"><start>148</start><end>153</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0064"><titleInfo><title>Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial</title></titleInfo><name type="personal"><namePart type="given">C.A.</namePart><namePart type="family">Laskin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.A.</namePart><namePart type="family">Spitzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.A.</namePart><namePart type="family">Clark</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.R.</namePart><namePart type="family">Crowther</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.S.</namePart><namePart type="family">Ginsberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.A.</namePart><namePart type="family">Hawker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.C.</namePart><namePart type="family">Kingdom</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Barrett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Gent</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Laskin, C.A., Spitzer, K.A., Clark, C.A., Crowther, M.R., Ginsberg, J.S., Hawker, G.A., Kingdom, J.C., Barrett, J. & Gent, M. (2009) Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Journal of Rheumatology, 36, 279–287.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>279</start><end>287</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Rheumatology</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>279</start><end>287</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0065"><titleInfo><title>The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo‐optical and mechanical coagulometers</title></titleInfo><name type="personal"><namePart type="given">A.S.</namePart><namePart type="family">Lawrie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.J.</namePart><namePart type="family">Mackie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Purdy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.J.</namePart><namePart type="family">Machin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lawrie, A.S., Mackie, I.J., Purdy, G. & Machin, S.J. (1999) The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo‐optical and mechanical coagulometers. Thrombosis and Haemostasis, 81, 758–762.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>758</start><end>762</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>758</start><end>762</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0066"><titleInfo><title>Antiphospholipid antibodies and subsequent thrombo‐occlusive events in patients with ischemic stroke</title></titleInfo><name type="personal"><namePart type="given">S.R.</namePart><namePart type="family">Levine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.L.</namePart><namePart type="family">Brey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.C.</namePart><namePart type="family">Tilley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.L.</namePart><namePart type="family">Thompson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.L.</namePart><namePart type="family">Sacco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.R.</namePart><namePart type="family">Sciacca</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Murphy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Lu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.M.</namePart><namePart type="family">Costigan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Rhine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Levin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.A.</namePart><namePart type="family">Triplett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.P.</namePart><namePart type="family">Mohr</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Levine, S.R., Brey, R.L., Tilley, B.C., Thompson, J.L., Sacco, R.L., Sciacca, R.R., Murphy, A., Lu, Y., Costigan, T.M., Rhine, C., Levin, B., Triplett, D.A. & Mohr, J.P. (2004) Antiphospholipid antibodies and subsequent thrombo‐occlusive events in patients with ischemic stroke. JAMA, 291, 576–584.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>291</number></detail><extent unit="pages"><start>576</start><end>584</end></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>291</number></detail><extent unit="pages"><start>576</start><end>584</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0067"><titleInfo><title>Dilute prothrombin time‐based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Liestol</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.M.</namePart><namePart type="family">Jacobsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Wisloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Liestol, S., Jacobsen, E.M. & Wisloff, F. (2002) Dilute prothrombin time‐based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin. Thrombosis Research, 105, 177–182.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>105</number></detail><extent unit="pages"><start>177</start><end>182</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis Research</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>105</number></detail><extent unit="pages"><start>177</start><end>182</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0068"><titleInfo><title>Management of antiphospholipid antibody syndrome: a systematic review</title></titleInfo><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Lim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Crowther</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.W.</namePart><namePart type="family">Eikelboom</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lim, W., Crowther, M.A. & Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA, 295, 1050–1057.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>295</number></detail><extent unit="pages"><start>1050</start><end>1057</end></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>295</number></detail><extent unit="pages"><start>1050</start><end>1057</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0069"><titleInfo><title>Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Male</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Lechner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Speiser</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Pabinger</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Male, C., Lechner, K., Speiser, W. & Pabinger, I. (2000) Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thrombosis and Haemostasis, 83, 174–175.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>174</start><end>175</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>174</start><end>175</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0070"><titleInfo><title>Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Malia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Kitchen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.E.</namePart><namePart type="family">Preston</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Malia, R.G., Kitchen, S., Greaves, M. & Preston, F.E. (1990) Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies [see comments]. British Journal Haematology, 76, 101–107.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>101</start><end>107</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal Haematology</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>101</start><end>107</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0071"><titleInfo><title>Anti‐phospholipid antibodies are directed against a complex antigen that includes a lipid‐binding inhibitor of coagulation: beta 2‐glycoprotein I (apolipoprotein H)</title></titleInfo><name type="personal"><namePart type="given">H.P.</namePart><namePart type="family">McNeil</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.J.</namePart><namePart type="family">Simpson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.N.</namePart><namePart type="family">Chesterman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.A.</namePart><namePart type="family">Krilis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McNeil, H.P., Simpson, R.J., Chesterman, C.N. & Krilis, S.A. (1990) Anti‐phospholipid antibodies are directed against a complex antigen that includes a lipid‐binding inhibitor of coagulation: beta 2‐glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences of the United States of America, 87, 4120–4124.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>4120</start><end>4124</end></extent></part><relatedItem type="host"><titleInfo><title>Proceedings of the National Academy of Sciences of the United States of America</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>4120</start><end>4124</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0072"><titleInfo><title>International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Miyakis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.D.</namePart><namePart type="family">Lockshin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.W.</namePart><namePart type="family">Branch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.L.</namePart><namePart type="family">Brey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Cervera</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Derksen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Koike</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Meroni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Reber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Shoenfeld</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tincani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">Vlachoyiannopoulos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.A.</namePart><namePart type="family">Krilis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., de Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295–306.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>295</start><end>306</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>295</start><end>306</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0073"><titleInfo><title>Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Montalban</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Cervera</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Font</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Ordi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Vianna</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.J.</namePart><namePart type="family">Haga</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Tintore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.R.</namePart><namePart type="family">Hughes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Montalban, J., Cervera, R., Font, J., Ordi, J., Vianna, J., Haga, H.J., Tintore, M., Khamashta, M.A. & Hughes, G.R. (1992) Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology, 42, 681–682.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>681</start><end>682</end></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>681</start><end>682</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0074"><titleInfo><title>Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants</title></titleInfo><name type="personal"><namePart type="given">G.W.</namePart><namePart type="family">Moore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.F.</namePart><namePart type="family">Savidge</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moore, G.W. & Savidge, G.F. (2004) Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants. Blood Coagulation and Fibrinolysis, 15, 279–282.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>279</start><end>282</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Coagulation and Fibrinolysis</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>279</start><end>282</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0075"><titleInfo><title>The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied</title></titleInfo><name type="personal"><namePart type="given">G.W.</namePart><namePart type="family">Moore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.F.</namePart><namePart type="family">Savidge</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moore, G.W. & Savidge, G.F. (2006) The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thrombosis Research, 118, 523–528.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>118</number></detail><extent unit="pages"><start>523</start><end>528</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis Research</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>118</number></detail><extent unit="pages"><start>523</start><end>528</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0076"><titleInfo><title>The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants</title></titleInfo><name type="personal"><namePart type="given">G.W.</namePart><namePart type="family">Moore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.P.</namePart><namePart type="family">Smith</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.F.</namePart><namePart type="family">Savidge</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moore, G.W., Smith, M.P. & Savidge, G.F. (2003) The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants. Blood Coagulation and Fibrinolysis, 14, 307–312.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>307</start><end>312</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Coagulation and Fibrinolysis</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>307</start><end>312</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0077"><titleInfo><title>Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy</title></titleInfo><name type="personal"><namePart type="given">G.W.</namePart><namePart type="family">Moore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Rangarajan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.J.</namePart><namePart type="family">Holland</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Henley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.F.</namePart><namePart type="family">Savidge</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moore, G.W., Rangarajan, S., Holland, L.J., Henley, A. & Savidge, G.F. (2005) Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy. British Journal of Biomedical Science, 62, 15–18; quiz 47.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>15</start><end>18</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal of Biomedical Science</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>15</start><end>18</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0078"><titleInfo><title>A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)</title></titleInfo><name type="personal"><namePart type="given">I.A.</namePart><namePart type="family">Naess</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.C.</namePart><namePart type="family">Christiansen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.C.</namePart><namePart type="family">Cannegieter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.R.</namePart><namePart type="family">Rosendaal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Hammerstroem</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Naess, I.A., Christiansen, S.C., Cannegieter, S.C., Rosendaal, F.R. & Hammerstroem, J. (2006) A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). Journal of Thrombosis and Haemostasis, 4, 44–49.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>44</start><end>49</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>44</start><end>49</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0079"><titleInfo><title>The potential role of heparin in assisted conception</title></titleInfo><name type="personal"><namePart type="given">S.M.</namePart><namePart type="family">Nelson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.A.</namePart><namePart type="family">Greer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nelson, S.M. & Greer, I.A. (2008) The potential role of heparin in assisted conception. Human Reproduction Update, 14, 623–645.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>623</start><end>645</end></extent></part><relatedItem type="host"><titleInfo><title>Human Reproduction Update</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>623</start><end>645</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0080"><titleInfo><title>Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low‐molecular‐weight heparin versus unfractionated heparin</title></titleInfo><name type="personal"><namePart type="given">L.S.</namePart><namePart type="family">Noble</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.H.</namePart><namePart type="family">Kutteh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Lashey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.D.</namePart><namePart type="family">Franklin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Herrada</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Noble, L.S., Kutteh, W.H., Lashey, N., Franklin, R.D. & Herrada, J. (2005) Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low‐molecular‐weight heparin versus unfractionated heparin. Fertility and Sterility, 83, 684–690.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>684</start><end>690</end></extent></part><relatedItem type="host"><titleInfo><title>Fertility and Sterility</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>684</start><end>690</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0081"><titleInfo><title>Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus</title></titleInfo><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Oger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Lernyer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Dueymes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Le Moigne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Bressolette</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Escoffre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Youinou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Mottier</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oger, E., Lernyer, C., Dueymes, M., Le Moigne, E., Bressolette, L., Escoffre, M., Youinou, P. & Mottier, D. (1997) Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus. Lupus, 6, 455–461.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>455</start><end>461</end></extent></part><relatedItem type="host"><titleInfo><title>Lupus</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>455</start><end>461</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0082"><titleInfo><title>Complement activation in patients with primary antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Oku</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Atsumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Bohgaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Amengual</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Kataoka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Horita</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Yasuda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Koike</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oku, K., Atsumi, T., Bohgaki, M., Amengual, O., Kataoka, H., Horita, T., Yasuda, S. & Koike, T. (2009) Complement activation in patients with primary antiphospholipid syndrome. Annals of the Rheumatic Diseases, 68, 1030–1035.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>1030</start><end>1035</end></extent></part><relatedItem type="host"><titleInfo><title>Annals of the Rheumatic Diseases</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>68</number></detail><extent unit="pages"><start>1030</start><end>1035</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0083"><titleInfo><title>Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Okuma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Kitagawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Yasuda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Tokuoka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Takagi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Okuma, H., Kitagawa, Y., Yasuda, T., Tokuoka, K. & Takagi, S. (2010) Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome. International Journal of Medical Sciences, 7, 15–18.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>15</start><end>18</end></extent></part><relatedItem type="host"><titleInfo><title>International Journal of Medical Sciences</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>15</start><end>18</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0084"><titleInfo><title>Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time</title></titleInfo><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Olteanu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.A.</namePart><namePart type="family">Downes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Patel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Praprotnik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Sarode</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Olteanu, H., Downes, K.A., Patel, J., Praprotnik, D. & Sarode, R. (2009) Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time. Clinical laboratory, 55, 138–142.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>138</start><end>142</end></extent></part><relatedItem type="host"><titleInfo><title>Clinical laboratory</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>138</start><end>142</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0085"><titleInfo><title>Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis</title></titleInfo><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Opatrny</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">David</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.R.</namePart><namePart type="family">Kahn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Shrier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Rey</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Opatrny, L., David, M., Kahn, S.R., Shrier, I. & Rey, E. (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. Journal of Rheumatology, 33, 2214–2221.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2214</start><end>2221</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Rheumatology</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2214</start><end>2221</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0086"><titleInfo><title>The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist</title></titleInfo><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Parmar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Lefkou</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Doughty</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Connor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.J.</namePart><namePart type="family">Hunt</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Parmar, K., Lefkou, E., Doughty, H., Connor, P. & Hunt, B.J. (2009) The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist. Blood Coagulation and Fibrinolysis, 20, 271–275.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>271</start><end>275</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Coagulation and Fibrinolysis</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>271</start><end>275</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0087"><titleInfo><title>Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial</title></titleInfo><name type="personal"><namePart type="given">N.S.</namePart><namePart type="family">Pattison</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.W.</namePart><namePart type="family">Chamley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Birdsall</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.M.</namePart><namePart type="family">Zanderigo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.S.</namePart><namePart type="family">Liddell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">McDougall</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pattison, N.S., Chamley, L.W., Birdsall, M., Zanderigo, A.M., Liddell, H.S. & McDougall, J. (2000) Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. American Journal of Obstetrics and Gynecology, 183, 1008–1012.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>183</number></detail><extent unit="pages"><start>1008</start><end>1012</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Obstetrics and Gynecology</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>183</number></detail><extent unit="pages"><start>1008</start><end>1012</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0088"><titleInfo><title>Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis</title></titleInfo><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Pengo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tripodi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Reber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.H.</namePart><namePart type="family">Rand</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.L.</namePart><namePart type="family">Ortel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">De Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pengo, V., Tripodi, A., Reber, G., Rand, J.H., Ortel, T.L., Galli, M. & De Groot, P.G. (2009) Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis, 7, 1737–1740.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>1737</start><end>1740</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>1737</start><end>1740</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0089"><titleInfo><title>Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Pengo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Ruffatti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Legnani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Gresele</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Barcellona</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Erba</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Testa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Marongiu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Bison</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Denas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Banzato</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Padayattil Jose</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Iliceto</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pengo, V., Ruffatti, A., Legnani, C., Gresele, P., Barcellona, D., Erba, N., Testa, S., Marongiu, F., Bison, E., Denas, G., Banzato, A., Padayattil Jose, S. & Iliceto, S. (2010) Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome. Journal of Thrombosis and Haemostasis, 8, 237–242.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>237</start><end>242</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>237</start><end>242</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0090"><titleInfo><title>Incidence of a first thromboembolic event in asymptomatic carriers of high risk antiphospholipid antibody profile: a multicenter prospective study</title></titleInfo><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Pengo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Ruffatti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Legnani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Testa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Fierro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Marongiu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">De Micheli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Gresele</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Tonello</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Ghirarduzzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Bison</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Denas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Banzato</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Padayattil Jose</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Iliceto</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pengo, V., Ruffatti, A., Legnani, C., Testa, S., Fierro, T., Marongiu, F., De Micheli, V., Gresele, P., Tonello, M., Ghirarduzzi, A., Bison, E., Denas, G., Banzato, A., Padayattil Jose, S. & Iliceto, S. (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high risk antiphospholipid antibody profile: a multicenter prospective study. Blood, 118, 4714–4718.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>118</number></detail><extent unit="pages"><start>4714</start><end>4718</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>118</number></detail><extent unit="pages"><start>4714</start><end>4718</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0091"><titleInfo><title>Point‐of‐care testing in haemostasis</title></titleInfo><name type="personal"><namePart type="given">D.J.</namePart><namePart type="family">Perry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.A.</namePart><namePart type="family">Fitzmaurice</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Kitchen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.J.</namePart><namePart type="family">Mackie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Mallett</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Perry, D.J., Fitzmaurice, D.A., Kitchen, S., Mackie, I.J. & Mallett, S. (2010) Point‐of‐care testing in haemostasis. British Journal of Haematology, 150, 501–514.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>150</number></detail><extent unit="pages"><start>501</start><end>514</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal of Haematology</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>150</number></detail><extent unit="pages"><start>501</start><end>514</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0092"><titleInfo><title>A protocol for determination of anticardiolipin antibodies by ELISA</title></titleInfo><name type="personal"><namePart type="given">S.S.</namePart><namePart type="family">Pierangeli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.N.</namePart><namePart type="family">Harris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pierangeli, S.S. & Harris, E.N. (2008) A protocol for determination of anticardiolipin antibodies by ELISA. Nature Protocols, 3, 840–848.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>840</start><end>848</end></extent></part><relatedItem type="host"><titleInfo><title>Nature Protocols</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>840</start><end>848</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0093"><titleInfo><title>High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">R.S.</namePart><namePart type="family">Rai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Clifford</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Cohen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Regan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rai, R.S., Clifford, K., Cohen, H. & Regan, L. (1995) High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Human Reproduction, 10, 3301–3304.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>3301</start><end>3304</end></extent></part><relatedItem type="host"><titleInfo><title>Human Reproduction</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>3301</start><end>3304</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0094"><titleInfo><title>Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Rai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Cohen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Dave</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Regan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ, 314, 253–257.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>314</number></detail><extent unit="pages"><start>253</start><end>257</end></extent></part><relatedItem type="host"><titleInfo><title>BMJ</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>314</number></detail><extent unit="pages"><start>253</start><end>257</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0095"><titleInfo><title>Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin‐V binding to phospholipids: a “lupus procoagulant” phenomenon</title></titleInfo><name type="personal"><namePart type="given">J.H.</namePart><namePart type="family">Rand</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X.X.</namePart><namePart type="family">Wu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.A.</namePart><namePart type="family">Andree</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.B.</namePart><namePart type="family">Ross</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Rusinova</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.G.</namePart><namePart type="family">Gascon‐Lema</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Calandri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.C.</namePart><namePart type="family">Harpel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rand, J.H., Wu, X.X., Andree, H.A., Ross, J.B., Rusinova, E., Gascon‐Lema, M.G., Calandri, C. & Harpel, P.C. (1998) Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin‐V binding to phospholipids: a “lupus procoagulant” phenomenon. Blood, 92, 1652–1660.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>92</number></detail><extent unit="pages"><start>1652</start><end>1660</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>92</number></detail><extent unit="pages"><start>1652</start><end>1660</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0096"><titleInfo><title>Hydroxychloroquine directly reduces the binding of antiphospholipid antibody‐beta2‐glycoprotein I complexes to phospholipid bilayers</title></titleInfo><name type="personal"><namePart type="given">J.H.</namePart><namePart type="family">Rand</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X.X.</namePart><namePart type="family">Wu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.S.</namePart><namePart type="family">Quinn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.P.</namePart><namePart type="family">Chen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.J.</namePart><namePart type="family">Hathcock</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.J.</namePart><namePart type="family">Taatjes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rand, J.H., Wu, X.X., Quinn, A.S., Chen, P.P., Hathcock, J.J. & Taatjes, D.J. (2008) Hydroxychloroquine directly reduces the binding of antiphospholipid antibody‐beta2‐glycoprotein I complexes to phospholipid bilayers. Blood, 112, 1687–1695.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>1687</start><end>1695</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>1687</start><end>1695</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0097"><titleInfo><title>Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?</title></titleInfo><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Reber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Boehlen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">de Moerloose</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Reber, G., Boehlen, F. & de Moerloose, P. (2008) Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream? Seminars in Thrombosis and Hemostasis, 34, 340–346.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>340</start><end>346</end></extent></part><relatedItem type="host"><titleInfo><title>Seminars in Thrombosis and Hemostasis</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>340</start><end>346</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0098"><titleInfo><title>Antiphospholipid syndrome: an evolving story</title></titleInfo><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Robertson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Robertson, B. & Greaves, M. (2006) Antiphospholipid syndrome: an evolving story. Blood Reviews, 20, 201–212.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>201</start><end>212</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Reviews</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>201</start><end>212</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0099"><titleInfo><title>Thrombophilia in pregnancy: a systematic review</title></titleInfo><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Robertson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Wu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Langhorne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Twaddle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Clark</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.D.</namePart><namePart type="family">Lowe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.D.</namePart><namePart type="family">Walker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Brenkel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Regan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.A.</namePart><namePart type="family">Greer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. & Greer, I.A. (2006) Thrombophilia in pregnancy: a systematic review. British Journal Haematology, 132, 171–196.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>171</start><end>196</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal Haematology</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>171</start><end>196</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0100"><titleInfo><title>Factor X and factor II activity levels do not always agree in warfarin‐treated lupus anticoagulant patients</title></titleInfo><name type="personal"><namePart type="given">T.K.</namePart><namePart type="family">Rosborough</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.M.</namePart><namePart type="family">Jacobsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.F.</namePart><namePart type="family">Shepherd</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rosborough, T.K., Jacobsen, J.M. & Shepherd, M.F. (2010) Factor X and factor II activity levels do not always agree in warfarin‐treated lupus anticoagulant patients. Blood Coagulation and Fibrinolysis, 21, 242–244.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>242</start><end>244</end></extent></part><relatedItem type="host"><titleInfo><title>Blood Coagulation and Fibrinolysis</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>242</start><end>244</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0101"><titleInfo><title>Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients</title></titleInfo><name type="personal"><namePart type="given">M.H.</namePart><namePart type="family">Rosove</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.M.</namePart><namePart type="family">Brewer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rosove, M.H. & Brewer, P.M. (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine, 117, 303–308.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>303</start><end>308</end></extent></part><relatedItem type="host"><titleInfo><title>Annals of Internal Medicine</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>303</start><end>308</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0102"><titleInfo><title>A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Ruiz‐Irastorza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.J.</namePart><namePart type="family">Hunt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Khamashta</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ruiz‐Irastorza, G., Hunt, B.J. & Khamashta, M.A. (2007) A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis and Rheumatism, 57, 1487–1495.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1487</start><end>1495</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis and Rheumatism</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1487</start><end>1495</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0103"><titleInfo><title>Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study</title></titleInfo><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Sacre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Brihaye</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Hyafil</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.M.</namePart><namePart type="family">Serfaty</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Escoubet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.C.</namePart><namePart type="family">Zennaro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Lidove</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.P.</namePart><namePart type="family">Laissy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Papo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sacre, K., Brihaye, B., Hyafil, F., Serfaty, J.M., Escoubet, B., Zennaro, M.C., Lidove, O., Laissy, J.P. & Papo, T. (2010) Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study. Arthritis and Rheumatism, 62, 2093–2100.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>2093</start><end>2100</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis and Rheumatism</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>2093</start><end>2100</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0104"><titleInfo><title>The role of complement in the antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">J.E.</namePart><namePart type="family">Salmon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Girardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Salmon, J.E. & Girardi, G. (2004) The role of complement in the antiphospholipid syndrome. Current Directions in Autoimmunity, 7, 133–148.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>133</start><end>148</end></extent></part><relatedItem type="host"><titleInfo><title>Current Directions in Autoimmunity</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>133</start><end>148</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0105"><titleInfo><title>Clinical significance of IgA anticardiolipin and anti‐beta2‐GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Samarkos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.A.</namePart><namePart type="family">Davies</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Gordon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Loizou</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Samarkos, M., Davies, K.A., Gordon, C. & Loizou, S. (2006) Clinical significance of IgA anticardiolipin and anti‐beta2‐GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clinical Rheumatology, 25, 199–204.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>199</start><end>204</end></extent></part><relatedItem type="host"><titleInfo><title>Clinical Rheumatology</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>199</start><end>204</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0106"><titleInfo><title>A quantitative, semi‐automated and computer‐assisted test for lupus anticoagulant</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Schjetlein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.E.</namePart><namePart type="family">Sletnes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Wisloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schjetlein, R., Sletnes, K.E. & Wisloff, F. (1993) A quantitative, semi‐automated and computer‐assisted test for lupus anticoagulant. Thrombosis Research, 69, 239–250.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>69</number></detail><extent unit="pages"><start>239</start><end>250</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis Research</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>69</number></detail><extent unit="pages"><start>239</start><end>250</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0107"><titleInfo><title>Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Schulman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Svenungsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Granqvist</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schulman, S., Svenungsson, E. & Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. American Journal of Medicine, 104, 332–338.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>332</start><end>338</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Medicine</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>332</start><end>338</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0108"><titleInfo><title>Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">J.M.</namePart><namePart type="family">Shamonki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.E.</namePart><namePart type="family">Salmon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Hyjek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.N.</namePart><namePart type="family">Baergen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shamonki, J.M., Salmon, J.E., Hyjek, E. & Baergen, R.N. (2007) Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. American Journal of Obstetrics and Gynecology, 196, 167 e161–165.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>196</number></detail><extent unit="pages"><start>167</start></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Obstetrics and Gynecology</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>196</number></detail><extent unit="pages"><start>167</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0109"><titleInfo><title>Incidence of venous thromboembolism in families with inherited thrombophilia</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Simioni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Sanson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Prandoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Tormene</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Friederich</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Girolami</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Gavasso</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Huisman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Buller</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ten Cate, J.</namePart><namePart type="family">Wouter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Girolami</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Prins</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simioni, P., Sanson, B., Prandoni, P., Tormene, D., Friederich, P., Girolami, B., Gavasso, S., Huisman, M., Buller, H., Wouter ten Cate, J., Girolami, A. & Prins, M. (1999) Incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis and Haemostasis, 81, 198–202.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>198</start><end>202</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>198</start><end>202</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0110"><titleInfo><title>Preparation of plasma for the detection of lupus anticoagulants and antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">K.E.</namePart><namePart type="family">Sletnes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Gravem</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Wisloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sletnes, K.E., Gravem, K. & Wisloff, F. (1992) Preparation of plasma for the detection of lupus anticoagulants and antiphospholipid antibodies. Thrombosis Research, 66, 43–53.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>43</start><end>53</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis Research</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>43</start><end>53</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0111"><titleInfo><title>Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Stegnar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Bozic</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Peternel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Kveder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Vene</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Rozman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stegnar, M., Bozic, B., Peternel, P., Kveder, T., Vene, N. & Rozman, B. (1991) Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thrombosis Research, 63, 433–443.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><extent unit="pages"><start>433</start><end>443</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis Research</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><extent unit="pages"><start>433</start><end>443</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0112"><titleInfo><title>Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin</title></titleInfo><name type="personal"><namePart type="given">M.D.</namePart><namePart type="family">Stephenson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.J.</namePart><namePart type="family">Ballem</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Tsang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Purkiss</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Ensworth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Houlihan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.H.</namePart><namePart type="family">Ensom</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stephenson, M.D., Ballem, P.J., Tsang, P., Purkiss, S., Ensworth, S., Houlihan, E. & Ensom, M.H. (2004) Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. Journal of Obstetrics and Gynaecology Canada, 26, 729–734.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>729</start><end>734</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Obstetrics and Gynaecology Canada</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>729</start><end>734</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0113"><titleInfo><title>Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Swadzba</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Iwaniec</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Pulka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">De Laat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">De Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Musial</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Swadzba, J., Iwaniec, T., Pulka, M., De Laat, B., De Groot, P.G. & Musial, J. (2011) Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. Journal of Thrombosis and Haemostasis, 9, 1776–1783.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1776</start><end>1783</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1776</start><end>1783</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0114"><titleInfo><title>Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Thom</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Ivey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Eikelboom</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Thom, J., Ivey, L. & Eikelboom, J. (2003) Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. Journal of Thrombosis and Haemostasis, 1, 2689–2691.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>2689</start><end>2691</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>2689</start><end>2691</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0115"><titleInfo><title>Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study</title></titleInfo><name type="personal"><namePart type="given">G.E.</namePart><namePart type="family">Tietjen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Day</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Norris</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Aurora</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Halvorsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.R.</namePart><namePart type="family">Schultz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.R.</namePart><namePart type="family">Levine</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tietjen, G.E., Day, M., Norris, L., Aurora, S., Halvorsen, A., Schultz, L.R. & Levine, S.R. (1998) Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology, 50, 1433–1440.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>1433</start><end>1440</end></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>1433</start><end>1440</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0116"><titleInfo><title>Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tincani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Allegri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Balestrieri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Reber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Sanmarco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Meroni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.C.</namePart><namePart type="family">Boffa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tincani, A., Allegri, F., Balestrieri, G., Reber, G., Sanmarco, M., Meroni, P. & Boffa, M.C. (2004) Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thrombosis Research, 114, 553–558.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>553</start><end>558</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis Research</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>553</start><end>558</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0117"><titleInfo><title>Marked variation in antiphospholipid antibodies during pregnancy: relationships to pregnancy outcome</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Topping</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Quenby</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Farquharson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Malia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Greaves</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Topping, J., Quenby, S., Farquharson, R., Malia, R. & Greaves, M. (1999) Marked variation in antiphospholipid antibodies during pregnancy: relationships to pregnancy outcome. Human Reproduction, 14, 224–228.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>224</start><end>228</end></extent></part><relatedItem type="host"><titleInfo><title>Human Reproduction</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>224</start><end>228</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0118"><titleInfo><title>Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tripodi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Chantarangkul</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Clerici</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Negri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Galli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.M.</namePart><namePart type="family">Mannucci</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tripodi, A., Chantarangkul, V., Clerici, M., Negri, B., Galli, M. & Mannucci, P.M. (2001) Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. British Journal Haematology, 115, 672–678.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>672</start><end>678</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal Haematology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>672</start><end>678</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0119"><titleInfo><title>Low‐dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Tulppala</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Marttunen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Soderstrom‐Anttila</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Foudila</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Ailus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Palosuo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Ylikorkala</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tulppala, M., Marttunen, M., Soderstrom‐Anttila, V., Foudila, T., Ailus, K., Palosuo, T. & Ylikorkala, O. (1997) Low‐dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction, 12, 1567–1572.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1567</start><end>1572</end></extent></part><relatedItem type="host"><titleInfo><title>Human Reproduction</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1567</start><end>1572</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0120"><titleInfo><title>Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case‐control study</title></titleInfo><name type="personal"><namePart type="given">R.T.</namePart><namePart type="family">Urbanus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Siegerink</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Roest</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.R.</namePart><namePart type="family">Rosendaal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.G.</namePart><namePart type="family">de Groot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Algra</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Urbanus, R.T., Siegerink, B., Roest, M., Rosendaal, F.R., de Groot, P.G. & Algra, A. (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case‐control study. Lancet Neurology, 8, 998–1005.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>998</start><end>1005</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet Neurology</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>998</start><end>1005</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0121"><titleInfo><title>Prevalence, follow‐up and clinical significance of the anticardiolipin antibodies in normal subjects</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Vila</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.C.</namePart><namePart type="family">Hernandez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.F.</namePart><namePart type="family">Lopez‐Fernandez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Batlle</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vila, P., Hernandez, M.C., Lopez‐Fernandez, M.F. & Batlle, J. (1994) Prevalence, follow‐up and clinical significance of the anticardiolipin antibodies in normal subjects. Thrombosis and Haemostasis, 72, 209–213.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>209</start><end>213</end></extent></part><relatedItem type="host"><titleInfo><title>Thrombosis and Haemostasis</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>209</start><end>213</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="bjh9037-cit-0122"><titleInfo><title>The presence of IgG antibodies against beta2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant</title></titleInfo><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Zoghlami‐Rintelen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Vormittag</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Sailer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Lehr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Quehenberger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Rumpold</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Male</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Pabinger</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zoghlami‐Rintelen, C., Vormittag, R., Sailer, T., Lehr, S., Quehenberger, P., Rumpold, H., Male, C. & Pabinger, I. (2005) The presence of IgG antibodies against beta2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. Journal of Thrombosis and Haemostasis, 3, 1160–1165.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>1160</start><end>1165</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Thrombosis and Haemostasis</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>1160</start><end>1165</end></extent></part></relatedItem></relatedItem><identifier type="istex">77FB09242F766C204AA3EDEAB0546B376358BD0C</identifier><identifier type="ark">ark:/67375/WNG-JMFFLXHG-G</identifier><identifier type="DOI">10.1111/j.1365-2141.2012.09037.x</identifier><identifier type="ArticleID">BJH9037</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2012 Blackwell Publishing Ltd© 2012 Blackwell Publishing Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-13</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JMFFLXHG-G/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D71 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001D71 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:77FB09242F766C204AA3EDEAB0546B376358BD0C
|texte= Guidelines on the investigation and management of antiphospholipid syndrome
}}
| This area was generated with Dilib version V0.6.33. |  |